J KEWENTER
Overview
Explore the profile of J KEWENTER including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Engaras B, KEWENTER J, Nilsson O, Wedel H, Hafstrom L
Eur J Surg Oncol
. 2001 Mar;
27(1):43-8.
PMID: 11237491
Aims: To establish a baseline and intraindividual fluctuations of the tumour markers CEA, CA 50 and CA 242 in patients cured from colorectal cancer, and to test the hypothesis that...
2.
Towler B, Irwig L, Glasziou P, Weller D, KEWENTER J
Cochrane Database Syst Rev
. 2000 May;
(2):CD001216.
PMID: 10796760
Background: Colorectal cancer is a leading cause of illness and death in the Western world. In Australia, the United Kingdom and the United States, it is the second commonest cancer...
3.
Engaras B, Hafstrom L, KEWENTER J, Nilsson O, Wedel H
Eur J Surg
. 1999 Apr;
165(2):110-6.
PMID: 10192567
Objective: To establish standard serum concentrations of carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 50 and CA 242 in cancer-free subjects in the age group during which cancers are likely to...
4.
Towler B, Irwig L, Glasziou P, KEWENTER J, Weller D, Silagy C
BMJ
. 1998 Aug;
317(7158):559-65.
PMID: 9721111
Objective: To review effectiveness of screening for colorectal cancer with faecal occult blood test, Hemoccult, and to consider benefits and harms of screening. Design: Systematic review of trials of Hemoccult...
5.
KEWENTER J
Lakartidningen
. 1998 Jul;
95(25):2950-2.
PMID: 9674365
Findings in large randomised studies in Europe and America show that colorectal cancer mortality can be reduced by faecal occult blood screening. Moreover, in the American study it was shown...
6.
Lindholm E, Berglund B, KEWENTER J, Haglind E
Scand J Gastroenterol
. 1997 Mar;
32(3):238-45.
PMID: 9085461
Background: We wanted to assess the worry created by a screening program for colorectal cancer with fecal occult blood testing. Methods: Six thousand three hundred and sixty-six individuals (47% men;...
7.
Brevinge H, Lindholm E, Buntzen S, KEWENTER J
Int J Colorectal Dis
. 1997 Jan;
12(5):291-5.
PMID: 9401844
Reduced mortality from colorectal cancer may be achieved by screening with faecal occult blood testing. Screening for neoplasia in the rectum and sigmoid colon with flexible sigmoidoscopy is suggested to...
8.
KEWENTER J, Brevinge H
Dis Colon Rectum
. 1996 Jun;
39(6):676-80.
PMID: 8646956
Background And Purpose: In an ongoing randomized screening study of 68,306 patients for early detection of colorectal neoplasm, those with positive Hemoccult II tests (Smith Kline Diagnostic, Sunnyvale, CA) were...
9.
Lindholm E, Berglund B, Haglind E, KEWENTER J
Scand J Gastroenterol
. 1995 Feb;
30(2):171-6.
PMID: 7732341
Background: Factors associated with attending screening for colorectal cancer with faecal occult blood testing was studied. Methods: Sixty-eight per cent of 34,144 subjects participated in the primary screening and/or rescreening...
10.
KEWENTER J, Brevinge H, Engaras B, Haglind E
Endoscopy
. 1995 Feb;
27(2):159-63.
PMID: 7601048
Background And Study Aims: In an ongoing screening study of 68,306 patients for early detection of colorectal cancer, those with a positive Hemoccult II test (H2) were examined with a...